Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes.
Saved in:
| Title: | Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes. |
|---|---|
| Authors: | Pison, Christophe1,2 (AUTHOR) cpison@chu-grenoble.fr, Shah, Pallav L.3 (AUTHOR), Slebos, Dirk-Jan4 (AUTHOR), Ninane, Vincent5 (AUTHOR), Janssens, Wim6 (AUTHOR), Perez, Thierry7 (AUTHOR), Kessler, Romain8 (AUTHOR), Deslee, Gaetan9 (AUTHOR), Garner, Justin L.3 (AUTHOR), Hartman, Jorine E.4 (AUTHOR), Degano, Bruno1,2 (AUTHOR), Mayr, Anna10 (AUTHOR), Mayse, Martin11 (AUTHOR), Peterson, Alexander D.11 (AUTHOR), Valipour, Arschang10 (AUTHOR) |
| Source: | Respiratory Research. Dec2021, Vol. 22 Issue 1, p1-7. 7p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
